# Final Selection - Med-Gemma Impact Challenge

**Date:** January 18, 2026 (Day 8)
**Decision:** FINAL

---

## Selected Tool

# RadAssist Pro
### AI-Powered Radiology Assistant with 3D & Longitudinal Capabilities

---

## Selection Summary

| Attribute | Value |
|-----------|-------|
| **Tool Name** | RadAssist Pro |
| **Category** | Diagnostic Support Tool |
| **Final Score** | 84/100 (A Grade) |
| **Selection Confidence** | 8/10 (High) |
| **Primary Innovation** | 3D Volumetric + Longitudinal Analysis |

---

## Why RadAssist Pro?

### 1. Maximum MedGemma Utilization
- Uses ALL THREE unique MedGemma 1.5 capabilities
- 2D image analysis (baseline)
- 3D volumetric analysis (unique differentiator)
- Longitudinal comparison (competitive moat)

### 2. Strong Infrastructure Foundation
- 60%+ already built
- 83 tests passing
- HIPAA-compliant security module
- Streamlit UI ready

### 3. Clear Clinical Impact
- Addresses radiology workflow bottleneck
- High-volume use case (chest imaging)
- Catches critical findings
- Reduces turnaround time

### 4. Competitive Differentiation
- No other open-source model can do 3D medical imaging
- Longitudinal tracking is unique capability
- Production-ready architecture

---

## Scope Definition

### MVP (Must Have)
- 2D chest X-ray analysis
- Structured findings generation
- Basic report generation
- Functional Streamlit UI
- Passing test suite

### Target (Should Have)
- Longitudinal comparison
- Side-by-side visualization
- Change detection
- 80%+ test coverage
- Professional polish

### Stretch (Nice to Have)
- 3D volumetric analysis
- Volume measurements
- Clinical expert validation
- Exceptional demo quality

---

## Risk Mitigation

| Risk | Mitigation |
|------|------------|
| 3D too complex | Fallback to 2D + longitudinal |
| Performance issues | Quantization, caching |
| Time overrun | Strict feature freeze Day 17 |
| Accuracy concerns | Prominent disclaimers |

---

## Timeline

- **Phase 3 (Days 11-25):** Core Development
- **Phase 4 (Days 26-32):** Refinement
- **Phase 5 (Days 33-37):** Final Testing & Submission
- **Submit:** February 19, 2026

---

## Approval

**Decision Maker:** Jeremy Potts (CEO/Competition Lead)
**Expert Panel:** Unanimous agreement
**Status:** APPROVED âœ…

---

*Document Version: 1.0*
*Last Updated: January 18, 2026*
